Cited by 148Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSirtuins and Resveratrol in Medicine

Cellular Senescence and the Biology of Aging, Disease, and Frailty

Open access
LeBrasseur, Nathan K., Tchkonia, Tamara, Kirkland, James L.·2015·Nestlé Nutrition Institute Workshop Series

Abstract

Population aging simultaneously highlights the remarkable advances in science, medicine, and public policy, and the formidable challenges facing society. Indeed, aging is the primary risk factor for many of the most common chronic diseases and frailty, which result in profound social and economic costs. Population aging also reveals an opportunity, i.e. interventions to disrupt the fundamental biology of aging could significantly delay the onset of age-related conditions as a group, and, as a result, extend the healthy life span, or health span. There is now considerable evidence that cellular senescence is an underlying mechanism of aging and age-related conditions. Cellular senescence is a process in which cells lose the ability to divide and damage neighboring cells by the factors they secrete, collectively referred to as the senescence-associated secretory phenotype (SASP). Herein, we discuss the concept of cellular senescence, review the evidence that implicates cellular senescence and SASP in age-related deterioration, hyperproliferation, and inflammation, and propose that this underlying mechanism of aging may play a fundamental role in the biology of frailty.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000382054

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Senotherapeutic drugs could potentially treat a variety of conditions primarily or secondarily mediated by senescent cell accumulation.

    “The use of senotherapeutic drugs could potentially be effective in treating a variety of conditions primarily or secondarily mediated by accumulation of senescent cells [6, 33, 67–87].”

    From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [72]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
LeBrasseur, N. K., Tchkonia, T., & Kirkland, J. L.
Venue
Nestlé Nutrition Institute Workshop Series
Publisher
S. Karger AG
Published
2015
Volume
83
Pages
11-18
ISSN
  • 1664-2147 (ISSN-L)
  • 1664-2155
OpenAlex
W1758822526
Cited by
147
References
31
Citations by year
2026: 6 · 2025: 7 · 2024: 12 · 2023: 17 · 2022: 9 · 2021: 26 · 2020: 20 · 2019: 19 · 2018: 12 · 2017: 12 · 2016: 7
FWCI
55.80
Type
conference paper
Language
en
Open access
Locations
  • Nestlé Nutrition Institute Workshop series (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Mayo Clinic
  • Glenn Foundation for Medical Research
  • National Institutes of Health
  • National Institute on Aging (AG-41122, P01AG041122)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senescence-associated secretory phenotype, aging, frailty, age-related diseases, healthspan, chronic inflammation, hyperproliferation, population aging
MeSH terms
Aged, 80 and over, Aging, Chronic Disease, Humans, Inflammation, Life Style, Models, Biological, Risk Factors, Frail Elderly, Cellular Senescence, Models, Immunological, Cell Proliferation, Elder Nutritional Physiological Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review